Literature DB >> 20961662

Cholinergic system function and cognition in mild cognitive impairment.

Cathleen Haense1, Elke Kalbe, Karl Herholz, Christoph Hohmann, Bernd Neumaier, Roman Krais, Wolf-Dieter Heiss.   

Abstract

Evidence for cholinergic dysfunction in very early stages of neurodegeneration like mild cognitive impairment (MCI) is inconclusive. Previous positron emission tomography (PET) studies based on small samples investigated if it is related to memory impairment. We examined whether cortical acetylcholine esterase (AChE) activity is reduced at this stage and correlated with cognitive function. N-[(11)C]-methyl-4-piperidyl acetate ([11C]MP4A), a positron emission tomography tracer for measuring cerebral AChE activity in vivo, was applied in 21 controls and 17 MCI patients. Parametric images of AChE activity were analyzed using standard atlas regions. Principal components analysis (PCA) of regional values of AChE activity and correlation analysis with neuropsychological test results was performed. Cortical AChE activity showed a significant decline in MCI patients compared with controls which was most pronounced in temporal regions. They formed the main part of a principal component that was related significantly to verbal and nonverbal memory, language comprehension and executive function. Cholinergic dysfunction is an early hallmark even before onset of dementia at the clinical stage of MCI. Its impact especially on temporal neocortex is associated with impaired neuropsychological function. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20961662     DOI: 10.1016/j.neurobiolaging.2010.08.015

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  41 in total

1.  Cerebrospinal fluid levels of Aβ42 relationship with cholinergic cortical activity in Alzheimer's disease patients.

Authors:  Alessandro Martorana; Zaira Esposito; Francesco Di Lorenzo; Viola Giacobbe; Giulia Maria Sancesario; Giulia Bucchi; Sonia Bonnì; Sergio Bernardini; Roberto Sorge; Giuseppe Sancesario; Giorgio Bernardi; Carlo Caltagirone; Giacomo Koch
Journal:  J Neural Transm (Vienna)       Date:  2012-03-09       Impact factor: 3.575

Review 2.  Mild cognitive impairment: pathology and mechanisms.

Authors:  Elliott J Mufson; Lester Binder; Scott E Counts; Steven T DeKosky; Leyla de Toledo-Morrell; Stephen D Ginsberg; Milos D Ikonomovic; Sylvia E Perez; Stephen W Scheff
Journal:  Acta Neuropathol       Date:  2011-11-19       Impact factor: 17.088

Review 3.  FDG-PET Contributions to the Pathophysiology of Memory Impairment.

Authors:  Shailendra Segobin; Renaud La Joie; Ludivine Ritz; Hélène Beaunieux; Béatrice Desgranges; Gaël Chételat; Anne Lise Pitel; Francis Eustache
Journal:  Neuropsychol Rev       Date:  2015-08-30       Impact factor: 7.444

4.  Kinetic modeling of [18 F]VAT, a novel radioligand for positron emission tomography imaging vesicular acetylcholine transporter in non-human primate brain.

Authors:  Hongjun Jin; Xuyi Yue; Hui Liu; Junbin Han; Hubert Flores; Yi Su; Stanley M Parsons; Joel S Perlmutter; Zhude Tu
Journal:  J Neurochem       Date:  2018-03-25       Impact factor: 5.372

5.  Neurotrophic factors rescue basal forebrain cholinergic neurons and improve performance on a spatial learning test.

Authors:  Yu-Shang Lee; Andalib Danandeh; Janie Baratta; Ching-Yi Lin; Jen Yu; Richard T Robertson
Journal:  Exp Neurol       Date:  2013-09-07       Impact factor: 5.330

6.  Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease.

Authors:  Stefan Teipel; Helmut Heinsen; Edson Amaro; Lea T Grinberg; Bernd Krause; Michel Grothe
Journal:  Neurobiol Aging       Date:  2013-10-28       Impact factor: 4.673

7.  Synchronization during an internally directed cognitive state in healthy aging and mild cognitive impairment: a MEG study.

Authors:  María Eugenia López; Pilar Garcés; Pablo Cuesta; Nazareth P Castellanos; Sara Aurtenetxe; Ricardo Bajo; Alberto Marcos; Mercedes Montenegro; Raquel Yubero; Francisco del Pozo; Miguel Sancho; Fernando Maestú
Journal:  Age (Dordr)       Date:  2014-06

8.  Study on Mechanism of Ginkgo biloba L. Leaves for the Treatment of Neurodegenerative Diseases Based on Network Pharmacology.

Authors:  Jing Wang; Xialin Chen; Weirong Bai; Zhenzhong Wang; Wei Xiao; Jingbo Zhu
Journal:  Neurochem Res       Date:  2021-05-14       Impact factor: 3.996

9.  BMP9 ameliorates amyloidosis and the cholinergic defect in a mouse model of Alzheimer's disease.

Authors:  Rebecca M Burke; Timothy A Norman; Tarik F Haydar; Barbara E Slack; Susan E Leeman; Jan Krzysztof Blusztajn; Tiffany J Mellott
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

10.  Alleviating effects of Bushen-Yizhi formula on ibotenic acid-induced cholinergic impairments in rat.

Authors:  Xue-Qin Hou; Lei Zhang; Cong Yang; Cui-Ping Rong; Wen-Qing He; Chun-Xia Zhang; Shi Li; Ru-Yu Su; Xiang Chang; Ji-Huan Qin; Yun-Bo Chen; Shao-Xiang Xian; Qi Wang
Journal:  Rejuvenation Res       Date:  2015-04       Impact factor: 4.663

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.